HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1- (3- C- ethynylribopentofuranosyl)cytosine

structure given in first source
Also Known As:
1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine; 3'-ethynylcytidine; 3-C-ethynyl-cytidine; ECyd cpd; TAS 106; TAS-106
Networked: 24 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Matsuda, Akira: 10 articles (05/2009 - 01/2002)
2. Sasaki, Takuma: 7 articles (05/2009 - 01/2002)
3. Fukushima, Masakazu: 7 articles (05/2009 - 01/2002)
4. Kazuno, Hiromi: 5 articles (05/2009 - 04/2002)
5. Mita, Akira: 3 articles (05/2012 - 06/2010)
6. Wataya, Yusuke: 3 articles (05/2009 - 01/2002)
7. Shimamoto, Yuji: 3 articles (06/2007 - 04/2002)
8. Inanami, Osamu: 3 articles (05/2007 - 12/2004)
9. Kuwabara, Mikinori: 3 articles (05/2007 - 12/2004)
10. Asanuma, Taketoshi: 3 articles (05/2007 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Squamous Cell Neoplasms (Squamous Cell Cancer)
4. Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. DNA-Directed RNA Polymerases (RNA Polymerase)
2. Platinum
3. Carboplatin (JM8)
4. Cisplatin (Platino)
5. RNA (Ribonucleic Acid)
6. 1- (3- C- ethynylribopentofuranosyl)cytosine
7. Nucleosides
8. Nucleic Acid Synthesis Inhibitors
9. Uridine Kinase
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)